Cooperative signaling between oncostatin M, hepatocyte growth factor and transforming growth factor-β enhances epithelial to mesenchymal transition in lung and pancreatic tumor models

Cells Tissues Organs

Volumn 193, Issue 1-2, 2010, Pages 114-132

  Argast, Gretchen M ^a   Mercado, Peter ^a   Mulford, Iain J ^a   O'Connor, Matthew ^a   Keane, David M ^a   Shaaban, Salam ^a   Epstein, David M ^a   Pachter, Jonathan A ^a   Kan, Julie L C ^a  

^a OSI PHARMACEUTICALS INC   (United States)

Author keywords

Cancer; Cell biology; Cytokines; Epithelial mesenchymal transition; Growth factors

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACTIN; ONCOSTATIN M; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN;

ARTICLE; BASEMENT MEMBRANE; CELL STIMULATION; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LUNG TUMOR; MALE; METASTASIS; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HEPATOCYTE GROWTH FACTOR; HUMANS; LUNG NEOPLASMS; MICROSCOPY, CONFOCAL; ONCOSTATIN M; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 78650516687     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320179     Document Type: Article

References (51)

1. Allington, T. M., W. P. Schiemann (2011) The cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells. Cells Tissues Organs 193:98-113.
2. Bamber, B., R. A. Reife, H. S. Haugen, C. H. Clegg (1998) Oncostatin M stimulates excessive extracellular matrix accumulation in a transgenic mouse model of connective tissue disease. J Mol Med 76:61-69.
3. Bates, R. C., A. M. Mercurio (2003) Tumor necrosis factor-alpha stimulates the epithelial-tomesenchymal transition of human colonic organoids. Mol Biol Cell 14:1790-1800.
4. Birchmeier, C, W. Birchmeier, E. Gherardi, G. F. Vande Woude (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915-925.
5. Bladt, F., D. Riethmacher, S. Isenmann, A. Aguzzi, C. Birchmeier (1995) Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376:768-771.
6. Boing, I., C. Stross, S. Radtke, B. E. Lippok, P. C. Heinrich, H. M. Hermanns (2006) Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases. Cel Signal 18:50-61.
7. Buck, E., A. Eyzaguirre, S. Barr, S. Thompson, R. Sennello, D. Young, K. K. Iwata, N. W. Gibson, P. Cagnoni, J. D. Haley (2007) Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther 6:532-541.
8. Buck, E., A. Eyzaguirre, E. Brown, F. Petti, S. McCormack, J. D. Haley, K. K. Iwata, N. W. Gibson, G. Griffin (2006a) Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors. Mol Cancer Ther 5:2676-2684.
9. Buck, E., A. Eyzaguirre, J. D. Haley, N. W. Gibson, P. Cagnoni, K. K. Iwata (2006b) Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity. Mol Cancer Ther 5:2051-2059.
10. Duband, J. L., F. Monier, M. Delannet, D. Newgreen (1995) Epithelium-mesenchyme transition during neural crest development. Acta Anat 154:63-78.
11. Fuchs, B. C., T. Fujii, J. D. Dorfman, J. M. Goodwin, A. X. Zhu, M. Lanuti, K. K. Tanabe (2008) Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 68:2391-2399.
12. Gal, A., T. Sjoblom, L. Fedorova, S. Imreh, H. Beug, A. Moustakas (2008) Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 27:1218-1230.
13. Gavert, N., A. Ben-Ze'ev (2008) Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 14:199-209.
14. Gomez-Lechon, M. J. (1999) Oncostatin M: signal transduction and biological activity. Life Sci 65:2019-2030.
15. Grande, M., A. Franzen, J. O. Karlsson, L. E. Ericson, N. E. Heldin, M. Nilsson (2002) Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 115:4227-4236.
16. Gravdal, K., O. J. Halvorsen, S. A. Haukaas, L. A. Akslen (2007) A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13:7003-7011.
17. Graveel, C. R., C. A. London, G. F. Vande Woude (2005) A mouse model of activating Met mutations. Cell Cycle 4:518-520.
18. Grotegut, S., D. von Schweinitz, G. Christofori, F. Lehembre (2006) Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 25:3534-3545.
19. Huber, M. A., N. Kraut, H. Beug (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17:548-558.
20. Illman, S. A., K. Lehti, J. Keski-Oja, J. Lohi (2006) Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J Cell Sci 119:3856-3865.
21. Jechlinger, M., S. Grunert, I. H. Tamir, E. Janda, S. Ludemann, T. Waerner, P. Seither, A. Weith, H. Beug, N. Kraut (2003) Expression profiling of epithelial plasticity in tumor progression. Oncogene 22:7155-7169.
22. Kasai, H., J. T. Allen, R. M. Mason, T. Kamimura, Z. Zhang (2005) TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res 6:56.
23. Kishimoto, T., S. Akira, M. Narazaki, T. Taga (1995) Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254.
24. Kitase, Y., K. Yamashiro, K. Fu, J. M. Richman, C. F. Shuler (2011) Spatiotemporal localization of periostin and its potential role in epithelial-mesenchymal transition during palatal fusion. Cells Tissues Organs 193:53-63.
25. Kohn, E. A., Z. Du, M. Sato, C.M. Van Schyndle, M. A. Welsh, Y. A. Yang, C. H. Stuelten, B. Tang, W. Ju, E. P. Bottinger, L. M. Wakefield (2010) A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGF-beta signaling in the mammary gland. Breast Cancer Res 12: R83 PMID: 20942910.
26. LaGamba, D., A. Nawshad, E. D. Hay (2005) Microarray analysis of gene expression during epithelial-mesenchymal transformation. Dev Dyn 234:132-142.
27. Lamouille, S., R. Derynck (2011) Emergence of the phosphoinositide 3-kinase-akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelialmesenchymal transition. Cells Tissues Organs 193:8-22.
28. Lee, J. M., S. Dedhar, R. Kalluri, E. W. Thompson (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973-981.
29. Mani, S. A., W. Guo, M. J. Liao, E. N. Eaton, A. Ayyanan, AY. Zhou, M. Brooks, F. Reinhard, C. C. Zhang, M. Shipitsin, L. L. Campbell, K. Polyak, C. Brisken, J. Yang, R. A. Weinberg (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
30. Medici, D., E. D. Hay, D. A. Goodenough (2006) Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Mol Biol Cell 17:1871-1879.
31. Mosley, B., C. De Imus, D. Friend, N. Boiani, B. Thoma, L. S. Park, D. Cosman (1996) Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271:32635-32643.
32. Ng, G, D. Winder, B. Muralidhar, E. Gooding, I. Roberts, M. Pett, G. Mukherjee, J. Huang, N. Coleman (2007) Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome. J Pathol 212:325-334.
33. Nieto, M. A. (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3:155-166.
34. Nightingale, J., S. Patel, N. Suzuki, R. Buxton, K. I. Takagi, J. Suzuki, Y. Sumi, A. Imaizumi, R. M. Mason, Z. Zhang (2004) Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. J Am Soc Nephrol 15:21-32.
35. Peinado, H., D. Olmeda, A. Cano (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev 7:415-428.
36. Pollack, V., R. Sarkozi, Z. Banki, E. Feifel, S. Wehn, G. Gstraunthaler, H. Stoiber, G. Mayer, R. Montesano, F. Strutz, H. Schramek (2007) Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling. Am J Physiol 293: F1714-F1726.
37. Ponzo, M. G., R. Lesurf, S. Petkiewicz, F. P. O'Malley, D. Pinnaduwage, I. L. Andrulis, S. B. Bull, N. Chughtai, D. Zuo, M. Souleimanova, D. Germain, A. Omeroglu, R. D. Cardiff, M. Hallett, M. Park (2009) Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci USA 106:12903-12908.
38. Queen, M. M., R. E. Ryan, R. G. Holzer, C. R. Keller-Peck, C. L. Jorcyk (2005) Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res 65:8896-8904.
39. Sanders, E. J., S. Prasad, N. Hu (1993) The involvement of TGF beta 1 in early avian development: gastrulation and chondrogenesis. Anat Embr yol 187:573-581.
40. Schmidt, L., F. M. Duh, F. Chen, T. Kishida, G. Glenn, P. Choyke, S. W. Scherer, Z. Zhuang, I. Lubensky, M. Dean, R. Allikmets, A. Chidambaram, U. R. Bergerheim, J. T. Feltis, C. Casadevall, A. Zamarron, M. Bernues, S. Richard, C. J. Lips, M. M. Walther, L. C. Tsui, L. Geil, M. L. Orcutt, T. Stackhouse, J. Lipan, L. Slife, H. Brauch, J. Decker, G. Niehans, M. D. Hughson, H. Moch, S. Storkel, M. I. Lerman, W. M. Linehan, B. Zbar (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68-73.
41. Schramek, H., E. Feifel, I. Marschitz, N. Golochtchapova, G. Gstraunthaler, R. Montesano (2003) Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells. Am J Physiol Cell Physiol 285: C652-C661.
42. Shimao, Y., K. Nabeshima, T. Inoue, M. Koono (1999) Role of fibroblasts in HGF/SF-induced cohort migration of human colorectal carcinoma cells: fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-beta1. Int J Cancer 82:449-458.
43. Shintani, Y., M. Maeda, N. Chaika, K. R. Johnson, M. J. Wheelock (2008) Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. Am J Respir Cell Mol Biol 38:95-104.
44. Takayama, H., W. J. LaRochelle, R. Sharp, T. Otsuka, P. K riebel, M. Anver, S. A. Aaronson, G. Merlino (1997) Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 94:701-706.
45. Tang, B., M. Vu, T. Booker, S. J. Santner, F. R. Miller, M. R. Anver, L. M. Wakefield (2003) TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 112:1116-1124.
46. Thomson, S., E. Buck, F. Petti, G. Griffin, E. Brown, N. Ramnarine, K. K. Iwata, N. Gibson, J. D. Haley (2005) Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res 65:9455-9462.
47. Turley, E. A., M. Veiseh, D. C. Radisky, M. J. Bissell (2008) Mechanisms of disease: epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression? Nat Clin Pract 5:280-290.
48. Valcourt, U., M. Kowanetz, H. Niimi, C. H. Heldin, A. Moustakas (2005) TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelialmesenchymal cell transition. Mol Biol Cell 16:1987-2002.
49. Wellner, U., J. Schubert, U. C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. zur Hausen, V. G. Brunton, J. Morton, O. Sansom, J. Schuler, M. P. Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, T. Brabletz (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11:1487-1495.
50. Xie, L., B. K. Law, A. M. Chytil, K. A. Brown, M. E. Aakre, H. L. Moses (2004) Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6:603-610.
51. Yauch, R. L., T. Januario, D. A. Eberhard, G. Cavet, W. Zhu, L. Fu, T. Q. Pham, R. Soriano, J. Stinson, S. Seshagiri, Z. Modrusan, C. Y. Lin, V. O'Neill, L. C. Amler (2005) Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res 11:8686-8698.